Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
PERCUTANEOUS ABSORPTION PREPARATION CONTAINING RIVASTIGMINE
Document Type and Number:
WIPO Patent Application WO/2012/087047
Kind Code:
A3
Abstract:
Disclosed is a percutaneous absorption preparation for treatment of dementia that comprises rivastigmine or its pharmaceutically acceptable salt as an active ingredient, a styrene-isoprene-styrene block copolymer, a tackifier resin, and a plasticizer, which preparation contains a small amount of rivastigmine but allows a sufficient amount of the active ingredient penetrated into the skin to achieve an effective treatment of dementia.

Inventors:
YU HYUN-SUK (KR)
LEE YOUNG-MOO (KR)
KIM HYUN-WOO (KR)
KIM HEE-SOOK (KR)
Application Number:
PCT/KR2011/009994
Publication Date:
August 16, 2012
Filing Date:
December 22, 2011
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
SAMYANG BIOPHARMACEUTICALS (KR)
TRANSDERM INC (KR)
YU HYUN-SUK (KR)
LEE YOUNG-MOO (KR)
KIM HYUN-WOO (KR)
KIM HEE-SOOK (KR)
International Classes:
A61K9/70; A61K31/27; A61P25/00; A61P25/28
Domestic Patent References:
WO2007064407A12007-06-07
WO1999034782A11999-07-15
Foreign References:
US20080044461A12008-02-21
US20040258741A12004-12-23
US20050129748A12005-06-16
KR20100080681A2010-07-12
Other References:
See also references of EP 2654739A4
Attorney, Agent or Firm:
YOU ME PATENT AND LAW FIRM (649-10 Yoksam-dong Kangnam-Ku, Seoul 135-080, KR)
Download PDF: